Meanwhile, low expression of IGSF10 primarily promotes the progression of lung adenocarcinoma (LUAD) through cell cycle dysregulation mediated by the p53‐p21 axis, and secondarily through alterations in cell adhesion signaling pathways. This evidence concerns the gene CDKN1A and lung adenocarcinoma.